GABEX
Price
$5.16
Change
+$0.05 (+0.98%)
Updated
Jun 2 closing price
Net Assets
451.39M
VIVAX
Price
$83.19
Change
+$0.71 (+0.86%)
Updated
Jun 2 closing price
Net Assets
237.83B
Interact to see
Advertisement

GABEX vs VIVAX

Header iconGABEX vs VIVAX Comparison
Open Charts GABEX vs VIVAXBanner chart's image
GABEX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
GABEX vs. VIVAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GABEX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 238B vs. GABEX (451M). GABEX pays higher dividends than VIVAX: GABEX (17.45) vs VIVAX (1.76). GABEX was incepted earlier than VIVAX: GABEX (34 years) vs VIVAX (34 years). GABEX (1.41) is less costly to investors than VIVAX (0.17). VIVAX is a more actively managed with annual turnover of: 8.00 vs. GABEX (0.00). VIVAX has a lower initial minimum investment than GABEX: VIVAX (0) vs GABEX (1000). VIVAX annual gain was more profitable for investors over the last year : 23.23 vs. GABEX (3.69). VIVAX return over 5 years is better than : 50.69 vs. GABEX (-21.02).
GABEXVIVAXGABEX / VIVAX
Total Expense Ratio1.410.17829%
Annual Report Gross Expense Ratio1.410.17829%
Fund Existence34 years34 years-
Gain YTD6.29310.66759%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets451M238B0%
Annual Yield % from dividends17.451.76992%
Returns for 1 year3.6923.2316%
Returns for 3 years-3.1053.16-6%
Returns for 5 years-21.0250.69-41%
Returns for 10 years-54.08150.43-36%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MBOT2.010.03
+1.52%
Microbot Medical
SII133.330.86
+0.65%
Sprott
STZ136.760.51
+0.37%
Constellation Brands
GNPX0.74-0.01
-1.99%
Genprex Inc.
QNST12.14-0.47
-3.73%
QuinStreet